IL4 and renal cell carcinoma: In the model of BALB/c mice with renal cell carcinoma (RCC), circulating levels of M2-like markers and pro-angiogenic cytokines, including IL-4, IL-10, IL-13, and VEGF-A, were reduced in endostatin-treated animals in comparison with non-treated control [221].